Serotonin Uptake InhibitorsCitalopramParoxetineFluoxetineAntidepressive Agents, Second-GenerationSertralineFluvoxamineCyclohexanolsAntidepressive AgentsAntidepressive Agents, TricyclicDepressive Disorder, MajorSerotonin Plasma Membrane Transport ProteinsDepressive DisorderSerotoninAdrenergic Uptake InhibitorsDepressionSerotonin SyndromeReceptor, Serotonin, 5-HT1AReceptors, Serotonin, 5-HT1PhenelzineSerotonin AntagonistsAnxiety Disorders8-Hydroxy-2-(di-n-propylamino)tetralinSerotonin Receptor AgonistsCognitive TherapyReceptor, Serotonin, 5-HT2AAutoreceptorsDrug CostsDrugs, GenericSerotonin 5-HT1 Receptor AgonistsDrug UtilizationPanic DisorderSerotonin 5-HT1 Receptor AntagonistsSerotonin AgentsReceptors, SerotoninPsychiatric Status Rating ScalesRaphe NucleiSerotonin 5-HT2 Receptor AntagonistsDrug Utilization ReviewBiomarkers, PharmacologicalMicrodialysisAnxietyAnti-Anxiety AgentsDrug InteractionsTreatment OutcomeTryptophan HydroxylaseHealth Care CostsCytochrome P-450 CYP2D6Abnormalities, Drug-InducedObsessive-Compulsive DisorderBenzodiazepinesDesipramineMedication Therapy ManagementDrug ResistanceSexual Dysfunction, PhysiologicalPindololMonoamine Oxidase InhibitorsPregnancy ComplicationsPsychotherapyInsurance, Pharmaceutical ServicesBehavior, AnimalSuicidal IdeationAntipsychotic AgentsCost SavingsDouble-Blind MethodSuicideDrug PrescriptionsRats, Sprague-DawleyNorepinephrine Plasma Membrane Transport ProteinsThiophenesFetal DevelopmentDrug Therapy, CombinationDose-Response Relationship, DrugCombined Modality TherapyPrenatal Exposure Delayed EffectsPersonality InventorySwimmingAnalysis of VarianceTime FactorsSex CharacteristicsBrainPiperazinesDatabases, FactualDrug SynergismPregnancyDenmarkMotor ActivityCross-Over StudiesNorepinephrineEmotionsCase-Control StudiesCohort StudiesRisk FactorsAge FactorsDrug Administration ScheduleComorbidityHippocampusRetrospective StudiesSeverity of Illness IndexPhysician's Practice Patterns